Which corticosteroids are commonly used to treat respiratory conditions?

Corticosteroids are commonly employed in the treatment of respiratory conditions due to their anti-inflammatory properties. Fluticasone and Beclomethasone dipropionate are both inhaled corticosteroids that specifically target inflammation within the airways, making them effective in the management of conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Fluticasone is well-known for its ability to reduce airway swelling and improve lung function, while Beclomethasone dipropionate also aids in controlling symptoms by decreasing the inflammatory response. By being delivered directly to the lungs via inhalation, these medications can provide localized treatment, minimizing systemic side effects often associated with oral or injectable corticosteroids.

The other choices include medications that are either not corticosteroids or are not primarily used for respiratory issues, making Fluticasone and Beclomethasone dipropionate the suitable options for this context.